New Zealand markets close in 29 minutes

  • NZX 50

    11,194.00
    -49.29 (-0.44%)
     

  • NZD/USD

    0.5924
    -0.0026 (-0.44%)
     

  • NZD/EUR

    0.5656
    -0.0017 (-0.31%)
     

  • ALL ORDS

    7,143.40
    -92.10 (-1.27%)
     

  • ASX 200

    6,946.20
    -87.00 (-1.24%)
     

  • OIL

    87.92
    -0.90 (-1.01%)
     

  • GOLD

    1,833.10
    -14.10 (-0.76%)
     

  • NASDAQ

    14,837.57
    +122.33 (+0.83%)
     

  • FTSE

    7,510.72
    -97.36 (-1.28%)
     

  • Dow Jones

    33,433.35
    -74.15 (-0.22%)
     

  • DAX

    15,247.21
    -139.37 (-0.91%)
     

  • Hang Seng

    17,250.09
    -559.57 (-3.14%)
     

  • NIKKEI 225

    31,365.92
    -393.96 (-1.24%)
     

  • NZD/JPY

    88.7410
    -0.3590 (-0.40%)
     

The FDA Just Approved an RSV Vaccine -- and It Isn't From Moderna or Pfizer

David Jagielski, The Motley Fool
·4-min read
The FDA Just Approved an RSV Vaccine -- and It Isn't From Moderna or Pfizer

Moderna (NASDAQ: MRNA) and Pfizer (NYSE: PFE) are two healthcare companies aiming to produce a vaccine for the respiratory syncytial virus (RSV). In trials, their vaccine candidates have been proving highly effective, and it may not be long before these COVID-19 vaccine makers are fighting for market share again -- this time in the RSV market. The Food and Drug Administration (FDA) recently approved an RSV vaccine, and it wasn't from either of these two companies.

Continue reading